a developer of novel anti-cancer medicines
Industry Biotechnology
A.I.dvisor indicates that over the last year, NCNA has been closely correlated with PIRS. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then PIRS could also see price increases.
Ticker / NAME | Correlation To NCNA | 1D Price Change % | ||
---|---|---|---|---|
NCNA | 100% | -7.10% | ||
PIRS - NCNA | 95% Closely correlated | -5.16% | ||
CDTX - NCNA | 93% Closely correlated | -2.52% | ||
NBY - NCNA | 92% Closely correlated | -0.43% | ||
WINT - NCNA | 92% Closely correlated | -60.67% | ||
RNAC - NCNA | 92% Closely correlated | -6.02% | ||
More |
Ticker / NAME | Correlation To NCNA | 1D Price Change % |
---|---|---|
NCNA | 100% | -7.10% |
cancer theme (87 stocks) | 25% Poorly correlated | +0.89% |
NCNA theme (22 stocks) | 23% Poorly correlated | -0.97% |
drugs theme (265 stocks) | 21% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 17% Poorly correlated | +5.56% |
europe theme (180 stocks) | 15% Poorly correlated | +0.17% |